Stock screenerAll disclosures →
EDGAR →
ACOG
Conviction 90HealthcareScan · Mon, Aug 10, 2026Bearish harami
ACOG$8.87-2.85%
ResistanceSupportVol 14Insider buyVol MA14 124.01K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price8.87
Change-2.85%
Gap-1.31%
Rel volume2.73×
Avg volume112.31K
Avg $ vol941.45K
SMA 208.44
SMA 507.47
SMA 2006.32
Price vs 50+18.77%
Price vs 200+40.31%
MA stackbullish
50/200 cross—
Supertrendup · 7.08
RSI (14)59
MACD hist-0.01
MACD cross—
Stoch %K / %D77 / 79
ADX (14)16
+DI / −DI18 / 11
RSI divergenceBearish
MACD divergenceBearish
ATR %+7.96%
ADR %9.04%
52w high9.99
52w low4.50
From 52w high-11.21%
Above 52w low+97.11%
New 52w highNo
SqueezeOn · 9d
Bollinger width16.26%
%B0.81
Donchian pos78.02%
Donchian high9.27
Donchian low7.45
AVWAP (52w high)6.76
vs AVWAP high+31.12%
AVWAP (52w low)6.75
vs AVWAP low+31.41%
OBV trendFlat
Chaikin MF (20)-0.10
Today vs 20d2.73×
Avg vol (14d)124.01K
Avg vol (20d)112.31K
Avg $ vol (20d)941.45K
Market cap193.14M
RS 3m (vs SPY)+44.22%
RS 6m (vs SPY)+88.77%
RS line new highNo
Trend template8/8
Technical rank89.2
1 week+5.22%
1 month+5.47%
3 months+45.41%
6 months+73.92%
1 year-2.85%
YTD+36.46%
P/E-9.34
P/B3.36
P/S18.90
P/FCF-9.34
EPS-1.18
Div yield—
ROE-35.97%
ROA-29.85%
Debt/Eq—
Current12.64
EV/EBITDA-6.14
Gross margin—
Net margin-202.24%
Rev growth—
EPS growth-39.77%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value138.89M
Revenue3.53M
Net income-6.48M
Gross profit—
Free cash flow-20.67M
IndustryBiological Products, (No Diagnostic Substances)
ExchangeNasdaq
Shares out21.77M
Employees71
ListedWed, Jun 9, 2021
Free float19.08M
Float %87.8%
Short interest215.58K
Days to cover3.5d
Short volume52.9%
Squeeze score43 / 100
Next earningsThu, Aug 13, 2026 · after (3d)
EPS forecast−$0.39 · 3 est
Last EPS vs est−$0.37 vs −$0.41
Last surprise+9.8% beat
Setup gradeA+
Conviction90 / 100
Pattern quality—
Tech rank89.2 / 100
Group rank—
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish harami
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ACOG
No recent disclosed trades by Congress in ACOG. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ACOG · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-07-24 | Buy | 130 | $1K | 2026-07-24 | 2026-07-28 |
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-06-26 | Buy | 152.34K | $975K | 2026-06-26 | 2026-06-29 |
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-06-25 | Buy | 197 | $1K | 2026-06-25 | 2026-06-29 |
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-09 |
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-06-05 | Buy | 10.05K | $59K | 2026-06-05 | 2026-06-09 |
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-29 | Buy | 70.58K | $416K | 2026-05-29 | 2026-05-29 |
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-28 | Buy | 2K | $12K | 2026-05-28 | 2026-05-29 |
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-27 | Buy | 1.16K | $7K | 2026-05-27 | 2026-05-29 |
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-29 |
Opaleye Management Inc. 10% owner · Common Stock, no par value · 2026-05-21 | Buy | 15.95K | $91K | 2026-05-21 | 2026-05-22 |
SEC filings
EDGAR filings in ACOG · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.